Sarah Cannon Research Institute
Emily S. is an experienced oncology project manager currently serving as an Oncology Senior Project Manager at Sarah Cannon Research Institute since August 2021, following a role as an Oncology Project Manager. Prior experience includes a position as Project Manager in Clinical Operations at Concentrics Research and as a Clinical Research Analyst at Pearl Pathways, where Emily contributed to project management and regulatory projects. Previous roles at PRA Health Sciences encompassed various levels of medical monitoring and project support, underscoring strong clinical operations expertise. Emily's foundational experience includes public health internships and roles in research and sustainability, complemented by a Master's degree in Healthcare Administration from the University of North Carolina at Chapel Hill and a Bachelor's degree in Biochemistry from the University of Wisconsin-Madison.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.